Europe is leading the way in the registration, launch and uptake of biologic medicines, and as a result, many Australian guidelines have been developed based on the European experience. Biosimilar medicines have been supplied within Europe for over a decade, and since 2006, EU-approved biosimilar medicines have generated more than 700 million patient days of … Continue reading The European Experience